Hepatic Oxalate Overproduction As A Driver And Therapeutic Target In NASH And Atherosclerosis

被引：0
|
作者：
Das, Sandeep
Finney, Alexandra C.
Kumar, Dhananjay
Liu, Yuhao
Rohilla, Sumati
Anand, Sumit Kumar
Nunez, Kelly
Liu, Zhipeng
Pearson-Gallion, Brenna
Abdullah, Chowdhury S.
Cockerham, Elizabeth D.
Bhuiyan, Md Shenuarin
Orr, Wayne W.
Garcia-Barrio, Minerva T.
Zhang, Jifeng
Liu, Wanqing
Chen, Y. Eugene
Thevenot, Paul
Cohen, Ari
Yurdagul, Arif
Rom, Oren
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2023年 / 43卷
关键词：
Atherosclerosis; Mitochondria; Metabolism;
D O I：
10.1161/atvb.43.suppl_1.684
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 684
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MD-2 as a possible therapeutic target for atherosclerosis
    Chen, Shuang
    Crother, Timothy R.
    EBIOMEDICINE, 2020, 55
  • [42] IL-17: A promising therapeutic target for atherosclerosis
    Fan, Zhixing
    Yang, Jian
    Yang, Chaojun
    Yang, Jun
    Guo, Xin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 930 - 931
  • [43] ABCG1 - A potential therapeutic target for atherosclerosis
    Ni, Zhan-ling
    Zhao, Shui-ping
    Wu, Zhihong
    MEDICAL HYPOTHESES, 2007, 69 (01) : 214 - 217
  • [44] ADAMTS7: a Novel Therapeutic Target in Atherosclerosis
    Chung, Allen
    Reilly, Muredach P.
    Bauer, Robert C.
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (08) : 447 - 455
  • [45] Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis
    Van der Veken, Bieke
    De Meyer, Guido R. Y.
    Martinet, Wim
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (10) : 1247 - 1257
  • [46] Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis
    Jensen, Hanna A.
    Mehta, Jawahar L.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (09) : 1021 - 1033
  • [47] Regulatory T cells as a new therapeutic target for atherosclerosis
    Ou, Han-xiao
    Guo, Bing-bing
    Liu, Qi
    Li, Yu-kun
    Yang, Zhen
    Feng, Wen-jie
    Mo, Zhong-cheng
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (08) : 1249 - 1258
  • [48] Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice
    Duan, Jingjing
    Wang, Zhuo
    Duan, Ran
    Yang, Chenxinhui
    Zhao, Ruolin
    Feng, Qi
    Qin, Yuanyuan
    Jiang, Jingwei
    Gu, Shouyong
    Lv, Kaiyan
    Zhang, Libo
    He, Bixia
    Birnbaumer, Lutz
    Yang, Song
    Chen, Zhen
    Yang, Yong
    HEPATOLOGY, 2022, 75 (01) : 140 - 153
  • [49] Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target
    Di Fusco, Stefania Angela
    Arca, Marcello
    Scicchitano, Pietro
    Alonzo, Alessandro
    Perone, Francesco
    Gulizia, Michele Massimo
    Gabrielli, Domenico
    Oliva, Fabrizio
    Imperoli, Giuseppe
    Colivicchi, Furio
    HEART, 2023, 109 (01) : 18 - 25
  • [50] Macrophages: An elusive yet emerging therapeutic target of atherosclerosis
    Tiwari, R. L.
    Singh, V.
    Barthwal, M. K.
    MEDICINAL RESEARCH REVIEWS, 2008, 28 (04) : 483 - 544
12345